In this work, we have synthesized 3,5-dihydrazinyl-4-nitro-1 H -pyrazole ( 2 ), 9-nitro-1 H -pyrazolo[3,2- c:5,1- c ′]bis([1,2,4]triazole)-3,6-diamine ( 3 ), and N–N-bonded N, N ′-{[4,4′-bi(1,2,4-triazole)]-3,3′-diyl}dinitramide ( 5 ) and its stable nitrogen-rich energetic salts in one and two steps in quantitative yields from commercially available inexpensive starting material 4,6-dichloro-5-nitropyrimidine ( 1 ). Along with characterization via nuclear magnetic resonance, infrared, differential scanning calorimetry, and elemental analysis, the structures of 2 and 4–8 were confirmed by single-crystal X-ray diffraction. Interestingly, 5–8 show excellent thermal stability (242, 221, 250, and 242 °C, respectively) compared to that of RDX (210 °C). Detonation velocities of 2, 4, 6, and 7 range from 8992 to 9069 m s –1, which are better than that of RDX (8878 m s –1 ) and close to that of HMX (9221 m s –1 ). All of these compounds are insensitive to impact (10–35 J) and friction (360 N) sensitivity. These excellent energetic performances, stabilities, and synthetic feasibilities make compounds 2, 4, 6, and 7 promising candidates as secondary explosives and potential replacements for the presently used benchmark explosives RDX and HMX.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: